Atrial fibrillation in carcinoid heart disease: The role of Serotonin. A review of the literature [1]

Clinical Research in Cardiology

Volumn 96, Issue 2, 2007, Pages 114-118

  Langer, Christoph ^a   Piper, Cornelia ^a   Vogt, Jürgen ^a   Heintze, Johannes ^a   Butz, Thomas ^a   Lindner, Olliver ^b   Burchert, Wolfram ^b   Kersting, C ^c   Horstkotte, Dieter ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; NUCLEOTIDE DERIVATIVE; SEROTONIN; SOMATOSTATIN;

CARCINOID SYNDROME; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; DEFIBRILLATOR; DIARRHEA; ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HEART RATE VARIABILITY; HEART SCINTISCANNING; HEART VENTRICLE TACHYCARDIA; HOSPITAL READMISSION; HOT FLUSH; HUMAN; LETTER; MITRAL VALVE REPLACEMENT; PHYSICAL EXAMINATION; SEROTONIN BLOOD LEVEL; SYNCOPE; TACHYCARDIA; ULTRASOUND;

EID: 33846933077     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-0463-y     Document Type: Letter

References (22)

1. Brachmann J, Hilbel T, Beyer T, Schols W, Karolyi L, Freigang K, Becker R, Bauer A, Kubler W (1996) New aspects of defibrillator therapy. Z Kardiol 85(Suppl 6):83-89
2. Daniel WG, Nellessen U, Schroder E, Nonnast-Daniel B, Bednarski P, Nikutta P, Lichtlen PR (1988) Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 11:1204-1211
3. Denney WD, Kemp WE Jr, Anthony LB, Oates JA, Byrd BF 3rd (1998) Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. J Am Coll Cardiol 32:1017-1022
4. Hoffmann J, Grimm W, Menz V, Wied M, Funck R, Arnold R, Maisch B (1999) Heart rate variability in carcinoid heart disease. Am J Cardiol 83:128-131, A129
5. Hoffmann J, Grimm W, Menz V, Wied M, Sprenger A, Arnold R, Maisch B (2001) Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion 63:35-42
6. Horstkotte D, Niehues R, Strauer BE (1991) Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J 12(Suppl B):55-60
7. James TN, Isobe JH, Urthaler F (1975) Analysis of components in a cardiogenic hypertensive chemoreflex. Circulation 52:179-192
8. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N (1990) Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 16:377-380
9. Kuruvilla A, Aiman R (1973) Influence of 5-hydroxytryptamine on experimentally induced atrial arrhythmias in dogs. Indian J Physiol Pharmacol 17:111-116
10. Lundin L, Norheim I, Landelius J, Oberg K, Theodorsson-Norheim E (1988) Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 77:264-269
11. Madan BR, Khanna NK, Godhwani JL, Pendse VK (1969) Role of 5-hydroxytryptamine in atrial arrhythmias - an experimental study in dogs. Indian J Physiol Pharmacol 13:233-237
12. Madan BR, Khanna NK, Godhwani JL, Pendse VK (1970) Changes in the 5-hydroxytryptamine (5-HT) content of the heart during ectopic ventricular arrhythmia and consequent to its reversion by quinidine. Indian J Med Res 58:130-134
13. Mattke S, Dorwarth U, Muller D, Hoffmann E, Markewitz A, Kaulbach H, Schmockel M, Steinbeck G (1994) Inadequate therapeutic effects of implantable cardioverter/defibrillators: etiology, therapy and prevention. Z Kardiol 83:359-365
14. Moertel CG, Sauer WG, Dockerty MB, Baggenstoss AH (1961) Life history of the carcinoid tumor of the small intestine. Cancer 14:901-912
15. Nanthakumar K, Dorian P, Paquette M, Greene M, Edwards J, Heng D, Noble J, Newman D (2003) Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol 8:215-220
16. Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, McGovern B, Guy M, Torchiana DF, Vlahakes GJ, Garan H, Ruskin JN (1995) Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation 91:2204-2213
17. Polster J, Klapdor R, Langenstein BA, Hanrath P (1982) Echocardiographic detection of tricuspid insufficiency in carcinoid heart syndrome - case report. Z Kardiol 71:689-690
18. Schneider JA, Yonkman FF (1953) Action of serotonin (5-hydroxytryptamine) on vagal afferent impulses in the cat. Am J Physiol 174:127-134
19. Tornebrandt K, Eskilsson J, Nobin A (1986) Heart involvement in metastatic carcinoid disease. Clin Cardiol 9:13-19
20. Weatherall M (1968) Drugs and excitable cell membranes. In: Robson JM, Stacey RS (eds) Recent advances in pharmacology. London, Churchill 7, 22
21. Weber M, Block M, Brunn J, Bansch D, Bocker D, Hammel D, Gietzen F, Breithardt G (1996) Inadequate therapies with implantable cardioverterdefibrillators - incidence, etiology, predictive factors and preventive strategies. Z Kardiol 85:809-819
22. Yusuf S, Al-Saady N, Camm AJ (2003) 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle? J Cardiovasc Electrophysiol 14:209-214